India Dacomitinib EGFR Inhibitor NSCLC

So, Dacomitinib is this medicine that targets a specific kind of lung cancer. It’s used for patients who have certain gene changes in their EGFR. It stops EGFR from sending those messages that lead to cancer growth.

You can get this medicine in different strengths: 15, 30, or 45 milligrams. The usual dose is 45 mg, and you take it every day. Each bottle holds 30 of those pills.

Dacomitinib works by zeroing in on that cancer-causing change in NSCLC patients, which makes it more effective. And it’s a pill you swallow, so it’s easy to take for a long time.